Clinical trialNCT01437774SuspendedInterventional

ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients

SponsorReverse Medical CorporationEnrollment210Ischemic Stroke

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The ReStore™ Thrombectomy device restores blood flow in the neurovascular by removing thrombus in patients experiencing ischemic stroke. Patients enrolled in the ReStore Trial will be randomized to treatment with the ReStore™ Thrombectomy Device (investigational treatment) or to treatment with a commercially available thrombectomy device It is expected that the investigational treatment safety profile in terms of clinically significant procedural adverse events will be comparable to the control group.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Marilyn M Rymer, MD
Mid America Brain and Stroke Institute, St Lukes Hospital, Kansas City MO
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Rush Medical Center
Chicago, Illinois, United States
St Luke'S Hospital of Kansas City
Kansas City, Missouri, United States
Oregon Health & Science University
Portland, Oregon, United States
Tennessee Interventional Associates, Erlanger Medical Ctr
Chattanooga, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2011
Primary completion: 30 Sept 2013
Completion: 31 Oct 2013
Last update posted: 6 Sept 2012
Registered enrollment: 210
Registry id: NCT01437774

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.